Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

HOPA 2018 | Thoughts on HOPA 2018 and what’s to come: progress in the Oncology Pharmacy community

Kirollos Hanna • 21 Mar 2018
HOPA 2018
General

Here, Kirollos Hanna, PharmD, BCOP, BCPS, of the University of Minnesota Medical Center, Minneapolis, MN, gives an insight into his experience of the 2018 Hematology/Oncology Pharmacy Association (HOPA) Annual Conference, held in Denver, CO. Dr Hanna also offers an insightful perspective into the benefits of HOPA and expresses his excitement for what is to come for the oncology pharmacy community.

More from Kirollos Hanna

3:45
Updates on immunotherapy options for metastatic urothelial carcinoma
Kirollos Hanna • 21 Mar 2018
1:49
HOPA 2018 updates on urothelial carcinoma: what is new?
Kirollos Hanna • 21 Mar 2018
3:50
Recommendations for the treatment of muscle and non-muscle invasive urothelial carcinoma
Kirollos Hanna • 21 Mar 2018
2:12
Looking towards the future: what is in store for the treatment of bladder cancer?
Kirollos Hanna • 21 Mar 2018

Related Videos

0:29
Innovative ctDNA-based liquid biopsy techniques for cancer diagnosis
Alain Thierry • 9 Apr 2024
0:50
Employing fragmentomics as a novel strategy to characterize and detect cancers
Alain Thierry • 9 Apr 2024
1:27
Emerging trials in melanoma: SWOG S1801, OpACIN-neo and PRADO
Christoffer Gebhardt • 9 Apr 2024
3:10
PALOMA: subcutaneous amivantamab in advanced solid tumors
Natasha Leighl • 17 Apr 2024
The content of VJOncology is intended for healthcare professionals